MiMedx Group (MDXG) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
MiMedx Group (MDXG) PT Raised to $15 at Needham & Company as Momentum Continues
February 27, 2015 8:34 AM ESTNeedham & Company analyst Mike Matson reiterated a Strong Buy rating and boosted his price target on MiMedx Group (NASDAQ: MDXG) to $15.00 (from $13.00) following Q4 results.
Matson commented, "MDXG's 4Q14 revenue was consistent with its 1/12/15 preannouncement while EPS met consensus. Management maintained its previously... More



